Innate Pharma Analyst Ratings
Analysts Have Conflicting Sentiments on These Healthcare Companies: Curis (CRIS), Health Catalyst (HCAT) and Innate Pharma SA (OtherIPHYF)
Analysts Offer Insights on Healthcare Companies: Qiagen (QGEN), Innate Pharma SA (OtherIPHYF) and Neumora Therapeutics, Inc. (NMRA)
Innate Pharma Analyst Ratings
Innate Pharma SA: A Balanced Hold Rating Amidst Clinical Setbacks and Cautious Optimism
Analysts Offer Insights on Healthcare Companies: Innate Pharma SA (OtherIPHYF), Medios AG (OtherMEDOF) and Tecan Group AG (OtherTCHBF)
Innate Pharma Analyst Ratings
Innate Pharma SA (IPHYF) Receives a Hold From Kepler Capital
Analysts Conflicted on These Healthcare Names: Innate Pharma SA (OtherIPHYF), Amgen (AMGN) and Regeneron (REGN)
Analysts Offer Insights on Healthcare Companies: Arcellx Inc (ACLX) and Innate Pharma SA (OtherIPHYF)
Analysts Offer Insights on Healthcare Companies: Innate Pharma SA (OtherIPHYF) and Medios AG (OtherMEDOF)
HC Wainwright & Co. Reiterates Buy on Innate Pharma, Maintains $11.5 Price Target
Innate Pharma Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Doximity (DOCS), Innate Pharma (IPHA) and Shockwave Medical (SWAV)
Kepler Capital Reaffirms Their Hold Rating on Innate Pharma SA (IPHYF)
HC Wainwright & Co. Reiterates Buy on Innate Pharma, Maintains $11.5 Price Target
Innate Pharma Analyst Ratings
Analysts Are Bullish on These Healthcare Stocks: Argenx Se (ARGX), Innate Pharma (IPHA)
Analysts Are Neutral on These Healthcare Stocks: Demant (WILLF), Innate Pharma SA (IPHYF)
Analysts Conflicted on These Healthcare Names: Clinuvel Pharmaceuticals Limited (OtherCLVLF), Medibank Private Ltd. (OtherMDBPF) and Innate Pharma SA (OtherIPHYF)
No Data